Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers:
4.1.1.1. Rising Incidence of Asthma and COPD
4.1.1.2. Increasing technological advancements
4.1.2. Restraints:
4.1.2.1. High cost of smart inhalers
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
6. By Type
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
6.1.2. Market Attractiveness Index, By Type Segment
6.2. Dry Powder Inhalers for the Smart Inhalers industry
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
6.3. Nasal Inhalers
6.4. Metered Dose Inhalers
6.5. Others
7. By Distribution Channel
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment
7.1.2. Market Attractiveness Index, By Distribution Channel Segment
7.2. Retail Pharmacies
7.2.1.1. Introduction
7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Respiratory Care Centers
7.4. Hospital Pharmacies
7.5. Online Pharmacies
8. By Indication
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication Segment
8.1.2. Market Attractiveness Index, By Indication Segment
8.2. Asthma
8.2.1.1. Introduction
8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Chronic obstructive pulmonary disease (COPD)
8.4. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
10. Competitive Landscape
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Types Benchmarking
10.4. List of Key Companies to Watch
11. Company Profiles
11.1. Teva Pharmaceuticals
11.1.1. Company Overview
11.1.2. Type Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Novartis
11.3. Vectura Group
11.4. MannKind
11.5. Respironics
11.6. Orion Pharm
11.7. Hovione
11.8. AstraZeneca
11.9. OPKO Health Inc
11.10. Boehringer-Ingelheim
11.11. 3M
11.12. BreatheSuite Inc
11.13. Sunovion Pharmaceuticals
11.14. Aristopharma
11.15. GlaxoSmithKline
11.16. Cohero Health LLC
LIST NOT EXHAUSTIVE
12. Global Smart Inhalers Market – DataM
12.1. Appendix
12.2. About Us and Indication
12.3. Contact Us